Marc Chioda - Search Results

Year	Number of Results
2011	1
2012	2
2013	1
2014	1
2015	1
2018	1
2019	2
2020	2
2021	1
2022	2
2024	0

1

Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER-medicare study.

Epstein RS, Nelms J, Moran D, Girman C, Huang H, Chioda M. Epstein RS, et al. Among authors: chioda m. Cancer Treat Res Commun. 2022;31:100555. doi: 10.1016/j.ctarc.2022.100555. Epub 2022 Apr 4. Cancer Treat Res Commun. 2022. PMID: 35421820 Free article.

2

Budget impact analysis of trilaciclib for decreasing the incidence of chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer in the United States.

Abraham I, Goyal A, Deniz B, Moran D, Chioda M, MacDonald KM, Huang H. Abraham I, et al. Among authors: chioda m. J Manag Care Spec Pharm. 2022 Apr;28(4):435-448. doi: 10.18553/jmcp.2022.21379. Epub 2022 Jan 31. J Manag Care Spec Pharm. 2022. PMID: 35100006

3

Trilaciclib and the economic value of multilineage myeloprotection from chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer treated with first-line chemotherapy.

Abraham I, Onyekwere U, Deniz B, Moran D, Chioda M, MacDonald K, Huang H. Abraham I, et al. Among authors: chioda m. J Med Econ. 2021 Nov;24(sup1):71-83. doi: 10.1080/13696998.2021.2014163. J Med Econ. 2021. PMID: 34873975 Free article. Clinical Trial.

4

Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer.

Waterhouse DM, Espirito JL, Chioda MD, Baidoo B, Mardekian J, Robert NJ, Masters ET. Waterhouse DM, et al. Among authors: chioda md. Drugs Real World Outcomes. 2020 Dec;7(4):261-269. doi: 10.1007/s40801-020-00207-6. Drugs Real World Outcomes. 2020. PMID: 32725539 Free PMC article.

5

Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners.

Reed M, Rosales AS, Chioda MD, Parker L, Devgan G, Kettle J. Reed M, et al. Among authors: chioda md. Adv Ther. 2020 Jun;37(6):3019-3030. doi: 10.1007/s12325-020-01365-3. Epub 2020 May 12. Adv Ther. 2020. PMID: 32399810 Free PMC article.

6

Clinical Management of Adverse Events Associated with Lorlatinib.

Bauer TM, Felip E, Solomon BJ, Thurm H, Peltz G, Chioda MD, Shaw AT. Bauer TM, et al. Among authors: chioda md. Oncologist. 2019 Aug;24(8):1103-1110. doi: 10.1634/theoncologist.2018-0380. Epub 2019 Mar 19. Oncologist. 2019. PMID: 30890623 Free PMC article.

7

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer.

Barrows SM, Wright K, Copley-Merriman C, Kaye JA, Chioda M, Wiltshire R, Torgersen KM, Masters ET. Barrows SM, et al. Among authors: chioda m. Lung Cancer (Auckl). 2019 Feb 8;10:11-20. doi: 10.2147/LCTT.S179349. eCollection 2019. Lung Cancer (Auckl). 2019. PMID: 30804692 Free PMC article. Review.

8

Real-World Use and Outcomes of ALK-Positive Crizotinib-Treated Metastatic NSCLC in US Community Oncology Practices: A Retrospective Observational Study.

Reynolds C, Masters ET, Black-Shinn J, Boyd M, Mardekian J, Espirito JL, Chioda M. Reynolds C, et al. Among authors: chioda m. J Clin Med. 2018 May 29;7(6):129. doi: 10.3390/jcm7060129. J Clin Med. 2018. PMID: 29844259 Free PMC article.

9

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR. Levy BP, et al. Among authors: chioda md. Oncologist. 2015 Oct;20(10):1175-81. doi: 10.1634/theoncologist.2015-0114. Epub 2015 Sep 1. Oncologist. 2015. PMID: 26330460 Free PMC article.

10

Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain.

Chobanian HR, Guo Y, Liu P, Chioda MD, Fung S, Lanza TJ, Chang L, Bakshi RK, Dellureficio JP, Hong Q, McLaughlin M, Belyk KM, Krska SW, Makarewicz AK, Martel EJ, Leone JF, Frey L, Karanam B, Madeira M, Alvaro R, Shuman J, Salituro G, Terebetski JL, Jochnowitz N, Mistry S, McGowan E, Hajdu R, Rosenbach M, Abbadie C, Alexander JP, Shiao LL, Sullivan KM, Nargund RP, Wyvratt MJ, Lin LS, DeVita RJ. Chobanian HR, et al. Among authors: chioda md. ACS Med Chem Lett. 2014 Apr 10;5(6):717-21. doi: 10.1021/ml5001239. eCollection 2014 Jun 12. ACS Med Chem Lett. 2014. PMID: 24944750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year